Search results
Abus Powerdome MIPS helmet review – affordable all-rounder but potential fit issues
Bike Perfect via Yahoo Sports· 12 months agoAbus Powerdome MIPS helmet The German security giant Abus has long been respected for its...
Twitter reacts to Sean Strickland’s TKO of Abus Magomedov at UFC on ESPN 47
MMA Junkie via Yahoo Sports· 11 months agoSean Strickland had top billing Saturday at UFC on ESPN 47 when he overcame an early eye poke to...
Updated ABUS Gamechanger 2.0: more aero, better ventilated and now with MIPS
Cycling Weekly via Yahoo News· 12 months agoABUS Gamechanger 2.0 aero bike helmet Abus has updated it's range-topping aero helmet with the...
Arbutus Biopharma Corp (ABUS) Reports Q3 2023 Financial Results
GuruFocus.com via Yahoo Finance· 7 months agoArbutus Biopharma Corp (NASDAQ:ABUS) reported Q3 2023 financial results on November 7, 2023. The...
Updated Abus GameChanger 2.0 helmet has better aerodynamics, ventilation and MIPS
Cycling News via Yahoo News· 12 months agoAbus Gamechanger 2.0 helmet The Abus GameChanger aero cycling helmet has been a fixture on the heads...
Arbutus (ABUS) to Focus on Hepatitis B Candidates, Stock Up
Zacks via Yahoo Finance· 9 months agoArbutus (ABUS) makes a strategic decision to focus on the development of hepatitis B virus therapies...
Arbutus Biopharma (ABUS) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoArbutus (ABUS) delivered earnings and revenue surprises of 23.08% and 165.39%, respectively, for the...
Arbutus Biopharma Corporation (NASDAQ:ABUS) has caught the attention of institutional investors who...
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights Institutions' substantial holdings in Arbutus Biopharma implies that they have...
Is Arbutus Biopharma (ABUS) Outperforming Other Medical Stocks This Year?
Zacks via Yahoo Finance· 1 year agoThe Medical group has plenty of great stocks, but investors should always be looking for companies...
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoArbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript February 29, 2024...